760 related articles for article (PubMed ID: 28199142)
1. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
[TBL] [Abstract][Full Text] [Related]
2. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.
Ishii T; Ruiz-Torruella M; Ikeda A; Shindo S; Movila A; Mawardi H; Albassam A; Kayal RA; Al-Dharrab AA; Egashira K; Wisitrasameewong W; Yamamoto K; Mira AI; Sueishi K; Han X; Taubman MA; Miyamoto T; Kawai T
FASEB J; 2018 Jul; 32(7):4016-4030. PubMed ID: 29533736
[TBL] [Abstract][Full Text] [Related]
3. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens.
Mensah KA; Ritchlin CT; Schwarz EM
J Cell Physiol; 2010 Apr; 223(1):76-83. PubMed ID: 20039274
[TBL] [Abstract][Full Text] [Related]
4. Effects of IL-34 and anti-IL-34 neutralizing mAb on alveolar bone loss in a ligature-induced model of periodontitis.
Duarte C; Yamada C; Ngala B; Garcia C; Akkaoui J; Birsa M; Ho A; Nusbaum A; AlQallaf H; John V; Movila A
Mol Oral Microbiol; 2024 Jun; 39(3):93-102. PubMed ID: 37902168
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation.
Yang M; Birnbaum MJ; MacKay CA; Mason-Savas A; Thompson B; Odgren PR
J Cell Physiol; 2008 May; 215(2):497-505. PubMed ID: 18064667
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
Nakane S; Imamura K; Hisanaga R; Ishihara K; Saito A
J Periodontal Res; 2021 Oct; 56(5):972-981. PubMed ID: 34129238
[TBL] [Abstract][Full Text] [Related]
7. Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology.
Witwicka H; Hwang SY; Reyes-Gutierrez P; Jia H; Odgren PE; Donahue LR; Birnbaum MJ; Odgren PR
PLoS One; 2015; 10(6):e0128275. PubMed ID: 26042409
[TBL] [Abstract][Full Text] [Related]
8. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell-cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2.
Takagi T; Inoue H; Takahashi N; Katsumata-Tsuboi R; Uehara M
Biosci Biotechnol Biochem; 2017 Jun; 81(6):1220-1223. PubMed ID: 28136694
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis.
Shindo S; Pierrelus R; Ikeda A; Nakamura S; Heidari A; Pastore MR; Leon E; Ruiz S; Chheda H; Khatiwala R; Kumagai T; Tolson G; Elderbashy I; Ouhara K; Han X; Hernandez M; Vardar-Sengul S; Shiba H; Kawai T
Cells; 2023 Apr; 12(8):. PubMed ID: 37190018
[TBL] [Abstract][Full Text] [Related]
11. Blocking of sodium and potassium ion-dependent adenosine triphosphatase-α1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis.
Makihira S; Nikawa H; Kajiya M; Kawai T; Mine Y; Kosaka E; Silva MJ; Tobiume K; Terada Y
Eur J Pharmacol; 2011 Nov; 670(2-3):409-18. PubMed ID: 21945676
[TBL] [Abstract][Full Text] [Related]
12. Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.
Kanzaki H; Movila A; Kayal R; Napimoga MH; Egashira K; Dewhirst F; Sasaki H; Howait M; Al-Dharrab A; Mira A; Han X; Taubman MA; Nichols FC; Kawai T
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):452-462. PubMed ID: 28153611
[TBL] [Abstract][Full Text] [Related]
13. Continuous application of compressive force induces fusion of osteoclast-like RAW264.7 cells via upregulation of RANK and downregulation of LGR4.
Matsuike R; Tanaka H; Nakai K; Kanda M; Nagasaki M; Murakami F; Shibata C; Mayahara K; Nakajima A; Tanabe N; Kawato T; Maeno M; Shimizu N
Life Sci; 2018 May; 201():30-36. PubMed ID: 29572179
[TBL] [Abstract][Full Text] [Related]
14. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
Ko SY
Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
[TBL] [Abstract][Full Text] [Related]
15. RANKL-induced DC-STAMP is essential for osteoclastogenesis.
Kukita T; Wada N; Kukita A; Kakimoto T; Sandra F; Toh K; Nagata K; Iijima T; Horiuchi M; Matsusaki H; Hieshima K; Yoshie O; Nomiyama H
J Exp Med; 2004 Oct; 200(7):941-6. PubMed ID: 15452179
[TBL] [Abstract][Full Text] [Related]
16. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
17. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.
Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J
Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096
[TBL] [Abstract][Full Text] [Related]
18. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH
Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902
[TBL] [Abstract][Full Text] [Related]
19. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.
Kim HJ; Hong J; Jung JW; Kim TH; Kim JA; Kim YH; Kim SY
Int Immunopharmacol; 2010 Nov; 10(11):1440-7. PubMed ID: 20831919
[TBL] [Abstract][Full Text] [Related]
20. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
